UTSW Internal Medicine Website

  • Increase font size
  • Default font size
  • Decrease font size
Residency Program > Residency Program > Resident Resources > NEJM - Central Venous Catheterization: US Guided Internal Jugular Vein

NEJM - Central Venous Catheterization: US Guided Internal Jugular Vein

Rafael Ortega, M.D., Michael Song, M.D., Christopher J. Hansen, M.A., and Paul Barash, M.D., N Engl J Med 2010; 362:e57April 22, 2010

About the Procedure

Traditionally, when internal jugular vein cannulation has been performed, external anatomical landmarks and palpation have been used to guide insertion of the needle into the vessel. However, depending on the operator's experience and the patient's anatomy, this procedure may be difficult or unsuccessful. Over the past decade, the increased use of ultrasound to guide internal jugular vein cannulation has improved success rates, reduced the time required to perform the procedure, and resulted in fewer complications. This technique requires an understanding of the neck anatomy as well as skill in performing and interpreting the results . . . .

Last Updated on Thursday, August 04 2011 09:39  

Only members can post comments. Please log in to post a comment.


Events & Seminars

Calendar

May 2012
Mo Tu We Th Fr Sa Su
1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30 31

Upcoming events

View full calendar

Calculators

Patient age
Barometric pressure
PaO2
PaCO2
FiO2
A-a Gradient
Normal A-a Gradient
Serum sodium
Serum glucose
Serum BUN
Calculated Osm
Bilirubin
Albumin
INR
Ascites
Encephalopathy
Child-Pugh score
Scoring:
A: 5-6
B: 7-9
C: 10-15
Patient age
Patient sex
Weight
 
Serum creatinine
eGFR
Calcium
Albumin
Corrected calcium

Serum sodium or BUN
Serum creatinine
Urine sodium or urea
Urine creatinine
Fractional excretion (%)


Serum sodium
Ideal sodium
Weight
 

Free water deficit (L)


For ischemic CVA the heparin dosing is as follows: no bolus, and 600-1000 units/hr drip (not weight-based). For other indications, use the calculator below.
Heparin indication

(For ACS, strongly consider LMWH instead of unfractionated heparin. Also, if using a IIb/IIIa inhibitor with unfractionated heparin, dose the unfractionated heparin as though the patient has a STEMI.)
 
Patient sex
Weight
Height
Heparin dosing weight (kg)
Bolus dose
*
Initial drip rate
*


*Maximum doses:
VTE 9000 bolus, 2000/hr gtt
NSTEMI 5000 bolus, 1000/hr gtt
STEMI 5000 bolus, 1000/hr gtt


Patient's sex
Weight
 
Height
Weight (kg)
BMI
Ideal body weight (kg)


Patient sex
Patient age
African-American?
Serum creatinine
eGFR / 1.73 m2

Bilirubin
INR
Creatinine*
*If the patient has been dialyzed at least twice within the last week, enter "4.0" for the serum creatinine.
MELD Score
Three-month mortality risk based on MELD Score:
Score
Mortality
‹10
4%
10-19
27%
20-29
76%
30-39
83%
40+
~100%

First drug
First drug dose (mg)
Second drug
Second drug dose (mg)

Note #1: Opioid analgesics have widely variable half lives, and when you switch from one form to another, you should adjust the scheduling accordingly.

Note #2: Methadone should be dosed by someone with experience using the drug. Consult palliative care or pain management.


QT (msec)
HR (bpm)
QTc (msec)


First steroid
Dose to convert (mg)
Second steroid
Second steroid dose (mg)

Age over 65
3 or more CAD risk factors
Prior coronary stenosis (50% or more)
ST segment deviation on initial ECG
2 or more anginal events in previous 24 hours
ASA use in last 7 days
Cardiac enzyme elevation
TIMI Score
TIMI Risk for cardiac event (mortality, new MI, or need for emergent revascularization) in the next 14 days:
 
Score
0-1
4.7%
 
2
8.3%
 
3
13.2%
 
4
19.9%
 
5
26.2%
 
6-7
40.9%
Serum potassium
Urine potassium
Serum osmolality
Urine osmolality
TTKG